• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

failure

  1. Ammon Labs Sale Revolt

    Is it true that all Ammon Reps quit? If true, what happened?

  2. Badhri Srinivasan

    A fish rots from the head down... You are not only an idiot, but also the worst kind of leader a company can expect: arrogant, ignorant and stubborn. Your crap decisions will have huge consequences not only for the associates who will lose their job, but also for the company. You can make as...
    • anonymous
    • Thread
    • bahdri failure fake gdo idiot noleader novartis srinivasan
    • Replies: 36
    • Forum: Novartis
Top Bottom
Back